深入了解病中的铁亡:事实和观点
Zhongyu Han1, Yuanke Luo1, Haoran Chen1
1School of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Kidney diseases (Basel, Switzerland)
|June 5, 2024
概括
铁,一种由铁和脂质过氧化驱动的细胞死亡形式,越来越多地与脏疾病有关. 了解铁灭症为治疗急性损伤和慢性病等疾病提供了新的途径.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 病理学 病理学 病理学
背景情况:
- 铁亡是一种独特的编程细胞死亡形式.
- 它涉及活性氧物种和依赖铁的脂质过氧化.
- 与亡,亡和自不同,铁亡具有独特的分子机制.
研究的目的:
- 审查病中铁亡的当前研究状况.
- 探索ferroptosis作为治疗目标的潜力.
- 要突出最近在理解铁亡相关的病理方面的突破.
主要方法:
- 关于铁亡和脏疾病研究的文献综述.
- 对涉及铁灭的分子通路的分析.
- 检查铁死在各种脏疾病中的作用.
主要成果:
- 铁性与急性损伤 (AKI),慢性病 (CKD),糖尿病病 (DN),多囊病 (PKD),狼性炎 (LN) 和细胞癌 (RCC) 有关.
- 像GPX4,TGF-β1,SLC7A11,NCOA4,mtDNA和氧化应激等特定的分子因素与不同病中的铁亡有关.
- 铁亡可以通过影响代谢和信号通路来加剧或减轻疾病的进展.
结论:
- 铁亡在各种脏疾病的发病过程中起着重要作用.
- 向铁亡途径为新型治疗干预提供了一个有希望的战略.
- 对铁灭菌机制的进一步研究对于推进病治疗至关重要.
相关概念视频
01:16Necrosis
4.4K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.4K
01:11Renal Failure: Dose Adjustments
84
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
84